A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.

Autor: Serhan M; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada., Psihogios A; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada., Kabir N; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada., Bota AB; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada., Mithani SS; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada., Smith DP; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada.; Institute of Mental Health Research, University of Ottawa, Ottawa, Canada., Zhu DT; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.; Yale School of Public Health, Yale University, New Haven, CT, USA., Greyson D; School of Population and Public Health, University of British Columbia, Vancouver, Canada., Wilson S; Health Protection, Public Health Ontario, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; Populations & Public Health Research Program, ICES, Toronto, ON, Canada., Fell D; Department of Pediatrics, Children's Hospital of Eastern Ontario (CHEO) Research Institute, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada., Top KA; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.; Departments of Pediatrics and Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada., Bettinger JA; Vaccine Evaluation Center, Department of Pediatrics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada., Wilson K; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.; Department of Medicine, University of Ottawa, Ottawa, Canada.; O'Neill Institute for National and Global Health Law, Georgetown University.; Bruyère Research Institute, Ottawa, Canada.
Jazyk: angličtina
Zdroj: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2293550. Date of Electronic Publication: 2024 Feb 19.
DOI: 10.1080/21645515.2023.2293550
Abstrakt: This scoping review examines the role of digital solutions in active, participant-centered surveillance of adverse events following initial release of COVID-19 vaccines. The goals of this paper were to examine the existing literature surrounding digital solutions and technology used for active, participant centered, AEFI surveillance of novel COVID-19 vaccines approved by WHO. This paper also aimed to identify gaps in literature surrounding digital, active, participant centered AEFI surveillance systems and to identify and describe the core components of active, participant centered, digital surveillance systems being used for post-market AEFI surveillance of WHO approved COVID-19 vaccines, with a focus on the digital solutions and technology being used, the type of AEFI detected, and the populations under surveillance. The findings highlight the need for customized surveillance systems based on local contexts and the lessons learned to improve future vaccine monitoring and pandemic preparedness.
Databáze: MEDLINE